Elizabeth Arden, Inc. (RDEN) Tops Q3 EPS by 3c; Guides Q4, FY12
Tweet
Share
E-mailGet Alerts RDEN Hot Sheet
Price: $13.98 --0%
Financial Fact:
Income from operations: -14.38M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Income from operations: -14.38M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Elizabeth Arden, Inc. (NASDAQ: RDEN) reported Q3 EPS of $0.07, $0.03 better than the analyst estimate of $0.04. Revenue for the quarter came in at $239.3 million versus the consensus estimate of $243.38 million.
Sees Q4 2012 revenue of $261-$267 million, versus the consensus of $264.02 million.
Sees FY2012 EPS of $1.95-$2.00, versus the consensus of $1.99.
For earnings history and earnings-related data on Elizabeth Arden, Inc. (RDEN) click here.
Sees Q4 2012 revenue of $261-$267 million, versus the consensus of $264.02 million.
Sees FY2012 EPS of $1.95-$2.00, versus the consensus of $1.99.
For earnings history and earnings-related data on Elizabeth Arden, Inc. (RDEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
- Kodiak Sciences Inc. (KOD) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
